(Q34929772)

5 August 2017

1 reference

title

From bench to bedside: a diagnostics framework for pharmacogenetics research (English)

1 reference

5 August 2017

David A Katz

1

1 reference

5 August 2017

publication date

1 September 2002

1 reference

Molecular Genetics and Metabolism

5 August 2017

published in

1 reference

5 August 2017

volume

77

1 reference

5 August 2017

issue

1-2

1 reference

5 August 2017

page(s)

57-60

1 reference

The incidence of alkaptonuria: a study in chemical individuality. 1902 [classical article]

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Enzymatic Deficiency in Primaquine-Sensitive Erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Genetic control of isoniazid metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Chemical regulation of pulmonary airway tone.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900143-9

7 January 2021

10.1016/S1096-7192(02)00143-9

Identifiers

DOI

1 reference

5 August 2017

1 reference